16results about "Phosphatide foodstuff compositions" patented technology

The utility model belongs to the field of phosphatidylserine production technology especially for a kind of efficient catalytic reaction kettle of preparation phosphatidylserine, including kettle body, the kettle body is by outer tube, and the inner tube of fixed connection on the inner wall of outer tube is composed, kettle body is located in the center of inner tube and is provided with stand, and stand is inserted with equidistant distribution's stirring catalytic mechanism, the stand includes the column body rotationally connected in the center of kettle body, and the outer wall of column body is along the length direction of column body and is provided with the T-shaped groove of array distribution.This utility model is through setting outer tube and inner tube, when using, the circulation of solution can be realized by circulating pipeline, conduit, liquid inlet pipe, water pump, liquid injection mechanism, so that solution reciprocating contact with enzyme catalysis board frame, avoid existing dead angle, and the mode can make that solution is heated evenly, in turn guarantee the preparation effect of phosphatidylserine, solved the device efficiency low, the problem of poor processing effect of present stage.

To provide: an edible microextruded product with compressive and tensile Young's moduli resembling the mechanical properties of meat; and a process of manufacturing the same.SOLUTION: An edible microextruded product includes one or more viscoelastic microextruded elements. The microextruded element include protein, an edible pseudoplastic polymer, and an edible solvent. The percentage by weight of the protein in relation with the total weight of the microextruded element is from 19% to 49%. The percentage by weight of the edible pseudoplastic polymer in relation with the total weight of the microextruded element is from 0.2% to 40%. The percentage by weight of the edible solvent in relation with the total weight of the microextruded element is at least 45%, the edible solvent balancing up to 100 wt.% of the microextruded element. The one or more microextruded elements have a cross-sectional width of from 10 μm to 1000 μm.SELECTED DRAWING: Figure 1A

A compound is represented by Formula (I),in which each carbon atom of a glycerol backbone optionally has one or more substituents, and R1 isoptionally having one or more substituents, in which * is an oxygen atom bound to R1.

This invention relates to the field of biological protein extraction technology, specifically disclosing an extraction process for marine biological proteins used for skin whitening in sensitive skin, comprising the following steps: S1, pretreatment; S2, acidic extraction; S3, enzymatic hydrolysis; S4, ultrafiltration and centrifugation. In the acidic extraction process, tannic acid, phytic acid, sulfonated soybean lecithin, and pepsin are added; in the enzymatic hydrolysis process, anthocyanins and magnesium gluconate are added. Through the synergistic effect of these processes, the purity and extraction rate of the marine biological protein are improved.

This disclosure relates to synthetic methods of making bioactive in vivo precursors to plasmalogen compounds and salts thereof and to making plasmalogens and their derivatives and salts thereof. This disclosure also relates to chemical precursors to bioactive compounds and salts thereof. This disclosure further relates to compositions comprising one or more compounds of this disclosure and the use of such compositions in preparing compounds useful in methods of treating diseases and conditions that are beneficially treated by administering plasmalogens or their derivatives or precursors that are transformed in vivo to plasmalogens.

The invention relates to a perovskite precursor solution, a perovskite thin film, a perovskite battery, and a power consumption device. The perovskite precursor solution contains a surfactant, the structure of which comprises a hydrophilic group, a hydrophobic group, and a first functional group, the first functional group being a Lewis base containing a lone pair of electrons, and the lone pair of electrons being located on at least one of the N atom and S atom.

This invention discloses a potent antioxidant active ingredient from Scutellaria baicalensis and hawthorn leaf, and its application in health supplements. Belonging to the field of active ingredient extraction technology, the active ingredient comprises Scutellaria baicalensis extract, hawthorn leaf extract, soybean lecithin, and a uniquely structured cyclohexanoylphenylphospholipid. This invention creatively combines the above raw materials through a steady-state compounding process, using cyclohexanoylphenylphospholipid prepared by reacting cyclohexanoyl chloride, 4-benzoyloxybenzoic acid, and glycerophosphatidylcholine. This component can enhance the binding between the active ingredient and the phospholipid carrier through intermolecular forces, significantly improving the physical and chemical stability of the product, effectively preventing degradation and inactivation of the active ingredient during storage, and enhancing its dissolution and penetration capabilities in a simulated gastrointestinal environment, thereby improving bioavailability. This active ingredient can be combined with excipients to prepare health supplements for antioxidant and lipid-regulating purposes, showing promising application prospects.

The invention provides methods for enhancing emulsification properties of a first protein, by fusing the first protein (preferably a dairy protein) with an oil body-associated protein, or a protein with affinity for an oil body-associated protein, to produce a fusion protein with at least one enhanced emulsification property relative to the first protein. The invention also provides fusion proteins produced by the methods, polynucleotides encoding and cells and plants expressing, the fusion proteins, and extracts from the cells and plants comprising the fusion proteins. The invention also methods for using the fusion proteins to produce emulsions, and sequestering proteins into such emulsions, and the emulsions and protein-enriched emulsions produced. The invention also provides for the use of the fusion proteins and emulsions in compositions, and for producing compositions, including food and beverage products, particularly in dairy, and dairy product substitutes, particularly in plant-based dairy product substitutes.

The present invention relates to a cyclic tetrapyrrole derivative, which can self-assemble, of formula (I), or one of the salts or conjugated acids or bases of this derivative.

The invention provides method for producing a composition containing oil body and dairy proteins by making an extract from a plant cell or plant expressing the dairy proteins, in close proximity to, or physical connection with, an oil body in the plant cell, plant part or 5 plant. In some embodiments the dairy proteins are expressed as fusions with oil-body associated proteins, or with components with affinity for oil body associated proteins. The invention provides methods for producing oil bodies functionalized with dairy proteins. The invention further provides constructs for expressing the fusion proteins, and cells and plants comprising the constructs, fusion proteins and functionalized oil bodies. The 10 invention provides the isolated functionalized oil bodies and fusion proteins and methods for their use in the production of various products including plant based dairy substitutes. The invention also provides various products comprising the functionalized oil bodies and fusion proteins.

The present disclosure provides an improved composition of ionizable lipid nanoparticles for delivering therapeutic nucleic acids to cells. Anionic phospholipids, including phosphatidylserine and phosphatidylglycerol, are included in lipid nanoparticles to increase transfection efficiency within human dendritic cells. Further incorporation of monounsaturated alkyl chain analogs in ionizable lipids of dimethylaminopropyl-dioxolane or heterocyclic ketal in the formulation demonstrated high levels of transfection within human dendritic cells and good stability against oxidative damage compared to other ionizable lipids of the same family. Finally, the use of the ammonium salt of phosphatidylserine enables the effective generation of PS-targeted LNPs.

The application provides a sphingomyelin-rich lipid, a preparation method and a phospholipid ingredient for infant formula milk powder, relates to the technical field of dairy processing, and utilizes supercritical carbon dioxide extraction technology for preliminary separation, and combines secondary extraction of subsequent ethanol as an entraining agent, so that non-polar lipids can be effectively removed, and high-polarity phospholipids, especially sphingomyelin, can be reserved. The ethanol concentration is controlled to be 20% (v / v), which is helpful to improve the solubility of the sphingomyelin-rich lipid and the selective extraction efficiency, so that higher sphingomyelin enrichment can be realized in the final product. Meanwhile, the application can also directly adopt ethanol extraction combined with a freezing crystallization method, in which no other organic solvents are introduced, the method is green and safe, and no complex equipment support is needed; the process flow is short, the operation is simple, the cost is low, and the method is suitable for rapid preparation.

The present invention relates to a method of preparing a protein composition, comprising enzymatic modification of milk lecithin using phospholipase. This protein composition is then included in nutritional products to increase emulsion quality and heat stability of the final nutritional products.

This invention discloses a method for the combined extraction of multiple components from egg yolk and its application, belonging to the field of food deep processing technology. The method involves centrifuging egg yolk liquid to obtain a slurry and egg yolk particles; the slurry undergoes secondary salting-out to obtain egg yolk immunoglobulin (IgY); the egg yolk particles are pretreated, mixed evenly with an organic solvent, centrifuged, and the precipitate is subjected to a secondary extraction to obtain egg yolk high-phosphorus protein (PV); the supernatant is subjected to low-temperature cold crystallization, centrifugation, and rotary evaporation; the evaporated product is mixed evenly with acetone and centrifuged to obtain precipitated lecithin (PL); the lipid supernatant generated during the extraction process is mixed and rotary evaporated to obtain egg yolk oil. This method achieves the combined extraction of multiple components such as IgY, PV, PL, and egg yolk oil. The process of this invention is simple to operate, low in cost, and has a high raw material utilization rate, making it suitable for large-scale industrial production. The extracted products can be widely used in the food, feed, and biopharmaceutical fields.

The application belongs to the technical field of medicine and chemical industry, and particularly relates to a synthesis method of 1,2-bifatty acyl-sn-glycerol-3-phosphatidic acid. The synthesis method of the liposome precursor compound 1,2-bifatty acyl-sn-glycerol-3-phosphatidic acid in the application is to perform a phosphorylation reaction on 1,2-bifatty acyl-sn-glycerol and phosphorus oxychloride as raw materials, and then to perform a hydrolysis reaction to obtain the required 1,2-bifatty acyl-sn-glycerol-3-phosphatidic acid. The two-step phosphorylation-hydrolysis reactions in the whole process can be performed under the bifunctional catalyst system, and the high-efficiency catalytic reaction can be realized without replacing the catalyst, and the product conversion rate is high.

The present invention relates to a sunflower phospholipid composition containing phosphatidylcholine and less than 0.1 wt. %, particularly less than 0.08 wt. % or less than 0.05 wt. %, and especially less than 0.02 wt. % chlorogenic acid, based on the total weight of the sunflower phospholipid composition, and its combination with at least one anionic stabilizer compound, including at least one anionic phospholipid compound. These combinations are particularly useful as emulsifiers in aqueous oil-in-water emulsions. The present invention also relates to an aqueous oil-in-water emulsion containing such a combination of a sunflower phospholipid composition and at least one anionic stabilizer compound, including at least one anionic phospholipid compound. The present invention also relates to a method for producing such an emulsion. The present invention particularly relates to a sunflower phospholipid composition comprising phosphatidylcholine in an amount of 45% by weight or more and having a low content of chlorogenic acid of less than 0.1% by weight and at least one anionic phospholipid compound.